Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
53.2M
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
29.9M
-
Shares change
-
+1.52M
-
Total reported value, excl. options
-
$213M
-
Value change
-
+$9.11M
-
Put/Call ratio
-
0.03
-
Number of buys
-
28
-
Number of sells
-
-40
-
Price
-
$7.12
Significant Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q3 2023
92 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share as of Q3 2023.
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.9M shares
of 53.2M outstanding shares and own 56.25% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (5.56M shares), RTW INVESTMENTS, LP (3.3M shares), Rubric Capital Management LP (2.71M shares), AIGH Capital Management LLC (2.21M shares), COWEN AND COMPANY, LLC (1.8M shares), BlackRock Inc. (1.73M shares), VANGUARD GROUP INC (1.22M shares), 5AM Venture Management, LLC (1.2M shares), MORGAN STANLEY (1.14M shares), and Thrivent Financial for Lutherans (1.04M shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.